(Q50027762)

English

First approval in sight for Novartis' CAR-T therapy after panel vote.

scientific article published in August 2017

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28787408

retrieved

23 February 2018

reference URL

http://europepmc.org/abstract/MED/28787408

title

First approval in sight for Novartis' CAR-T therapy after panel vote. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28787408

retrieved

23 February 2018

reference URL

http://europepmc.org/abstract/MED/28787408

author name string

Cormac Sheridan

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28787408

retrieved

23 February 2018

reference URL

http://europepmc.org/abstract/MED/28787408

publication date

1 August 2017

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28787408

retrieved

23 February 2018

reference URL

http://europepmc.org/abstract/MED/28787408

published in

Nature Biotechnology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28787408

retrieved

23 February 2018

reference URL

http://europepmc.org/abstract/MED/28787408

volume

35

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28787408

retrieved

23 February 2018

reference URL

http://europepmc.org/abstract/MED/28787408

issue

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28787408

retrieved

23 February 2018

reference URL

http://europepmc.org/abstract/MED/28787408

page(s)

691-693

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28787408

retrieved

23 February 2018

reference URL

http://europepmc.org/abstract/MED/28787408

exact match

https://scigraph.springernature.com/pub.10.1038/nbt0817-691

0 references

cites work

CAR-T cells forge ahead, Novartis reorganizes.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNBT0817-691

retrieved

21 January 2018

CAR-T death strikes Kite

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1038%2FNBT0817-691

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1038/NBT0817-691

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28787408

retrieved

23 February 2018

reference URL

http://europepmc.org/abstract/MED/28787408

Dimensions Publication ID

1091104647

0 references

Fatcat ID

release_3nnzypc5pjhtfhuzz3oe777wli

1 reference

stated in

Fatcat

reference URL

https://api.fatcat.wiki/v0/release/3nnzypc5pjhtfhuzz3oe777wli

retrieved

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

28787408

1 reference

stated in

Europe PubMed Central

PubMed publication ID

28787408

retrieved

23 February 2018

reference URL

http://europepmc.org/abstract/MED/28787408

(Q50027762)

First approval in sight for Novartis' CAR-T therapy after panel vote.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)